Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

Stoecklein NH, Hosch SB, Bezler M, Stern F, Hartmann CH, Vay C, Siegmund A, Scheunemann P, Schurr P, Knoefel WT, Verde PE, Reichelt U, Erbersdobler A, Grau R, Ullrich A, Izbicki JR, Klein CA.

Cancer Cell. 2008 May;13(5):441-53. doi: 10.1016/j.ccr.2008.04.005.

2.

Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer.

Hosch S, Kraus J, Scheunemann P, Izbicki JR, Schneider C, Schumacher U, Witter K, Speicher MR, Pantel K.

Cancer Res. 2000 Dec 15;60(24):6836-40.

3.

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.

Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.

Ann Surg Oncol. 2008 Oct;15(10):2894-902. doi: 10.1245/s10434-008-0084-y. Epub 2008 Jul 29.

PMID:
18663531
4.

Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.

Buergy D, Fuchs T, Kambakamba P, Mudduluru G, Maurer G, Post S, Tang Y, Nakada MT, Yan L, Allgayer H.

Cancer. 2009 Oct 15;115(20):4667-78. doi: 10.1002/cncr.24516.

5.
6.

Combined transcriptome and genome analysis of single micrometastatic cells.

Klein CA, Seidl S, Petat-Dutter K, Offner S, Geigl JB, Schmidt-Kittler O, Wendler N, Passlick B, Huber RM, Schlimok G, Baeuerle PA, Riethm├╝ller G.

Nat Biotechnol. 2002 Apr;20(4):387-92.

PMID:
11923846
7.

Total number of resected lymph nodes predicts survival in esophageal cancer.

Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M.

Ann Surg. 2008 Aug;248(2):221-6. doi: 10.1097/SLA.0b013e31817bbe59.

PMID:
18650631
8.

CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.

Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, Saito H, Minamiya Y, Satoh S, Murata K, Suzuki T, Ogawa J.

Ann Surg Oncol. 2009 Sep;16(9):2479-85. doi: 10.1245/s10434-009-0525-2. Epub 2009 Jun 3.

PMID:
19495883
9.

Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13.

PMID:
19526206
10.

Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.

Wang C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NC, Pintilie M, Miller N, Youngson B, McCready DR, Done SJ.

Genes Chromosomes Cancer. 2009 Dec;48(12):1091-101. doi: 10.1002/gcc.20711.

PMID:
19760610
11.

Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors.

Łastowska M, Cotterill S, Bown N, Cullinane C, Variend S, Lunec J, Strachan T, Pearson AD, Jackson MS.

Genes Chromosomes Cancer. 2002 Aug;34(4):428-36.

PMID:
12112532
12.

Impact of disseminated tumor cells in gastrointestinal cancer.

Thorban S, Rosenberg R, Maak M, Friederichs J, Gertler R, Siewert JR.

Expert Rev Mol Diagn. 2006 May;6(3):333-43. Review.

PMID:
16706737
13.

Differential gene expression profiling of esophageal adenocarcinoma.

Hammoud ZT, Badve S, Zhao Q, Li L, Saxena R, Thorat MA, Morimiya A, Rieger KM, Kesler KA.

J Thorac Cardiovasc Surg. 2009 Apr;137(4):829-34. doi: 10.1016/j.jtcvs.2008.08.052.

14.

Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.

Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, Lang H, Junginger T, Hansen T.

J Surg Oncol. 2009 Sep 1;100(3):191-8. doi: 10.1002/jso.21336.

PMID:
19548259
15.

Impact of the number of resected and involved lymph nodes on esophageal cancer survival.

Chen YJ, Schultheiss TE, Wong JY, Kernstine KH.

J Surg Oncol. 2009 Aug 1;100(2):127-32. doi: 10.1002/jso.21312.

PMID:
19544364
16.

Prediction of lymph node status in superficial esophageal carcinoma.

Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, Portale G, Cavallin F, Rugge M.

Ann Surg Oncol. 2008 Nov;15(11):3278-88. doi: 10.1245/s10434-008-0065-1. Epub 2008 Aug 26.

PMID:
18726651
17.

Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus.

Lagarde SM, Ver Loren van Themaat PE, Moerland PD, Gilhuijs-Pederson LA, Ten Kate FJ, Reitsma PH, van Kampen AH, Zwinderman AH, Baas F, van Lanschot JJ.

Ann Surg Oncol. 2008 Dec;15(12):3459-70. doi: 10.1245/s10434-008-0165-y. Epub 2008 Sep 30.

PMID:
18825457
18.

Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.

Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.

Thorac Cardiovasc Surg. 2009 Oct;57(7):403-8. doi: 10.1055/s-0029-1185820. Epub 2009 Sep 30.

PMID:
19795327
19.

Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma.

Klein CA, Stoecklein NH.

Cancer Res. 2009 Jul 1;69(13):5285-8. doi: 10.1158/0008-5472.CAN-08-4586. Epub 2009 Jun 23. Review.

20.

Oesophageal cancer: assessment of response and follow up.

Rankin SC.

Cancer Imaging. 2007 Oct 1;7 Spec No A:S67-9. Review.

Supplemental Content

Support Center